Skip to main content
OpenTrials
Completed

NCT Number: NCT03026777

Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation

Endotracheal intubation is common in the care of critically ill patients. Complications of airway management in this setting are frequently encountered and may be associated with an increased risk of death. The prevention of complications during urgent and emergent endotracheal intubation is a key focus for airway management research. Post-intubation hypotension (PIH), a common complication of endotracheal intubation in the critically ill, may be prevented by a bolus of intravenous fluid prior to the start of the procedure, but this approach has not been examined in a prospective trial. There are no randomized trials of intravenous fluid administration to prevent PIH in critically ill adults. The investigators propose a randomized trial of fluid loading to prevent PIH in critically ill adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Alabama Birmingham, Birmingham, Alabama, United States

Loading trial locations.

About this study

The investigators propose a randomized, parallel-group trial evaluating the impact of fluid loading to decrease cardiovascular collapse during and after endotracheal intubation in critically ill adults. Patients admitted to the study sites who are deemed by their clinical team to require intubation and fulfill inclusion criteria without meeting exclusion criteria will be enrolled and randomly assigned to intravenous fluid loading versus none. All other decisions regarding airway management will remain at the discretion of the treating provider. Data will be collected at the time of intubation and prospectively from the medical record in order to determine the effect of the assigned intervention on short- and long-term outcomes. All data are collected non-invasively and are already a part of clinical data obtained in usual ICU care at the bedside or in the medical record. No additional data will be collected that is not observed at the bedside or obtained from the medical record.

Study Population: The study population will be all critically ill adults for whom the clinical team has decided to perform endotracheal intubation using sedation with or without neuromuscular blockade. Patients will be excluded only if the operator feels: 1. Additional intravenous fluids in the form of fluid loading is absolutely indicated or contraindicated, or 2. The urgency of the intubation would make performing the study procedures unsafe. Patients will be included regardless of gender, race, weight or body mass index, initial oxygen saturation, anticipated grade of view, and other clinical factors.

Study Interventions:

Fluid Loading - (1) 500 milliliters of an intravenous crystalloid solution of the operator's choosing will be (2) infused at any time after randomization and prior to the administration of procedural medications from (3) above the level of the central or peripheral intravenous or intraosseus access used and allowed to infuse by gravity and (4) stopped after 500 mL have infused. All intravenous infusions preceding the decision to perform endotracheal intubation will not be altered.

No Fluid Loading - No intravenous fluids are started after the decision is made to perform endotracheal intubation. All intravenous infusions preceding the decision to perform endotracheal intubation will not be altered.

Primary Endpoint:

Cardiovascular collapse - a composite endpoint defined as one or more of the following:

  • Death within 1 hour of intubation
  • Cardiac arrest within 1 hour of intubation
  • New systolic blood pressure < 65 mmHg between induction and 2 minutes after completion of intubation
  • New or increased vasopressor receipt between induction and 2 minutes after completion of intubation

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is admitted to participating study unit
  • Planned procedure is endotracheal intubation and planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit
  • Administration of sedation with or without neuromuscular blockade is planned
  • Age ≥ 18 years old

Exclusion criteria

  • Operator believes fluid loading to be absolutely indicated or contraindicated for the safe care of the patient
  • Urgency of intubation precludes safe performance of study procedures
  • Pregnancy
  • Prisoners
  • Age < 18 years old

Treatment and study plan

intravenous crystalloid fluid, 500 mL

Drug

Primary outcomes

  1. Number of Participants With Cardiovascular Collapse

    Time frame: 1 hour

    a composite endpoint defined as one or more of the following:

    • Death within 1 hour of intubation
    • Cardiac arrest within 1 hour of intubation
    • New systolic blood pressure < 65 mmHg between induction and 2 minutes after completion of intubation
    • New or increased vasopressor receipt between induction and 2 minutes after completion of intubation

Secondary outcomes

  1. In-hospital Mortality

    Time frame: from date of randomization through study completion, an average of 28 days

    What was the patient's vital status at the time of hospital discharge

  2. Ventilator-free Days

    Time frame: from date of randomization through study completion, an average of 28 days

    Number of days alive and free of invasive ventilation in a 28-day period

  3. ICU-free Days

    Time frame: from date of randomization through study completion, an average of 28 days

    Number of days alive and outside of an ICU in a 28 day period

  4. Lowest Arterial Oxygen Saturation

    Time frame: between induction and 2 minutes following procedure

    Lowest arterial oxygen saturation between induction and 2 min after intubation

  5. Number of Laryngoscopy Attempts

    Time frame: during procedure

    Number of laryngoscopy attempts to achieve successful tracheal intubation

  6. Lowest Systolic Blood Pressure

    Time frame: between induction and 2 minutes following procedure

    Lowest systolic blood pressure between induction and 2 min after intubation

Sponsors and collaborators

Lead sponsor

Louisiana State University Health Sciences Center in New Orleans

Other

Registry information

Official study title

Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation: The PrePARE Trial

Acronym: PrePARE

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jan 20, 2017
Registry last updated
Jan 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.